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Abstract
We present the hypothesis that an accumulation of dysfunctional mitochondria initiates a signaling 
cascade leading to motor neuron and muscle fiber death and culminating in sarcopenia. 
Interactions between neural and muscle cells that contain dysfunctional mitochondria exacerbate 
sarcopenia. Preventing sarcopenia will require identifying mitochondrial sources of dysfunction 
that are reversible.
Graphical abstract
Summary for TOC: Sarcopenia is characterized by fiber atrophy and loss of fibers. Mitochondria 
health determine death signaling leading to localized protein loss and if unchecked, widespread 
loss of muscle fibers.
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Introduction
Sarcopenia, is associated with increased levels of apoptosis (47) and reduced capabilities for 
muscle regeneration (41) leading to muscle wasting. For this reason, many studies including 
our own have focused on the muscle specific signaling that contribute to muscle wasting in 
sarcopenia. However, sarcopenia in aged humans and rodents is also associated with motor 
neuronal death (96, 139), which causes impaired innervation (48, 106), and a ~27% 
reduction in the motor unit pool. In aging, a loss of innervation induces profound muscle 
atrophy (5, 106, 129). Some denervated fibers become innervated by axons from surviving 
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motor neurons (42, 45), whereas other fibers remain denervated and contribute to functional 
losses in sarcopenia (42).
We postulate that the tight relationship between the loss of motor neurons and muscle cells 
in aging is explained by a common underlying mechanism that initiates deterioration in 
these cells. It is interesting that a loss of mitochondria function with aging is a mechanism 
that is shared by both muscle cells (18, 63) and motor neurons (123). Our current 
perspective and hypothesis is that mitochondrial deterioration in muscles and motor neurons 
is the primary initiator of sarcopenia (Figure 1). We have identified some of the data that 
support this perspective, and the areas that are speculative and require additional work to test 
this hypothesis.
Mitochondrial regulation of sarcopenia - Hypothesis
Aging increases mitochondrial stress that sensitizes the opening of the mitochondria 
transition permeability pore (mPTP). A loss of mitophagy-proteasome-induced 
mitochondrial clearance in muscle and motor neuron cells promotes accumulation of poorly 
functioning mitochondria that have increased mPTP opening. Leakage of the mitochondrial 
contents to the cell cytosol initiates death (apoptosis) signaling in muscle cells and motor 
neurons, which contributes to nuclear DNA fragmentation and if not repaired, nuclear 
apoptosis. Removal of nuclei in muscle cells and motor neurons leads to fiber and motor 
neuron death and loss of innervation to the muscle cells. Cross talk between muscles and 
motor neurons that contain dysfunctional mitochondria exacerbates sarcopenia. Thus, 
mitochondria are key initiators and regulators of sarcopenia (Figure 1).
Sources for mitochondrial damage in aging muscles and motor neurons—Our 
working hypothesis is that sarcopenia is initiated by an aging-associated insult to 
mitochondria in muscle cells and motor neurons. Mitochondrial stress in aging can originate 
from greater levels of oxidants, DNA damage, or denervation (31, 133).
Reactive oxygen species (ROS) induced damage—Aging increases ROS 
production (22), and lowers antioxidant enzymes levels in muscle and neuron cells (58, 59, 
121). ROS production might be secondary to denervation that occurs in muscles from old 
animals or humans (48, 55, 133). The accumulation of ROS has the potential to damage 
cellular mitochondria (reviewed in (15)). The importance of antioxidants in sarcopenia is 
highlighted by observations that both neural and muscle losses of the cytosolic antioxidant 
CuZn-superoxide dismutase (CuZnSOD) recapitulated sarcopenic muscle loss in a mouse 
model (125). It is noteworthy that the absence of CuZnSOD in either neural or muscle cells 
did not manifest full sarcopenic muscle loss (125). However, this observation highlights the 
need to consider cross talk between these two tissues in aging. Whatever the initial source(s) 
of ROS production, it is clear that accumulation of excessive ROS contributes to damaged 
and dysfunctional mitochondria in muscle and neural cells.
Mitochondrial DNA damage and aging in motor neurons and muscle cells—
Mitochondrial DNA (mtDNA) deletions or DNA mutations contribute to mitochondrial 
dysfunction and aging-related muscle fiber loss and atrophy (50, 90). In neurons, DNA 
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damage precedes neuronal apoptosis (85), whereas forced repair of DNA damage rescues 
neurons from elimination by apoptosis (86). Indeed, increased mtDNA mutations have been 
found in fiber regions that contain oxidative damage (2, 90). Furthermore, aging-induced 
mtDNA deletions are closely associated with a loss of mitochondrial function in motor 
neurons (123), neuronal malfunction in diseases like Parkinson’s disease (115), and muscle 
loss with aging (50, 91). While elevated ROS production is not solely the result of mtDNA 
deletions or mtDNA mutations (141), it is clear that this mechanism contributes to 
mitochondrial ROS production in aging muscles and neurons (26, 86, 91).
Mitochondria permeability transition pore sensitization with aging – 
mitochondrial dysfunction
Stress-induced damage to mitochondrial membranes (40, 108, 144, 147) contributes to 
sensitization of the mitochondrial permeability transition pore (mPTP) (44). The mPTP is a 
large conductance pore in the inner mitochondrial membrane, which is predominantly closed 
under non-stressed conditions. Opening of the mPTP can be induced by ROS, increased 
concentrations of Ca2+, or mitochondrial depolarization. mPTP opening is further 
exacerbated by an imbalance of Ca2+ homeostasis that likely results from leaky ryanodine 
receptors in aged skeletal muscle (10). Excessive Ca2+ loading leads to mitochondrial 
swelling, and rupture of the outer mitochondrial membrane.
Opening the mPTP induces a further loss of mitochondrial membrane potential, and releases 
the mitochondrial contents to the cytosol to initiate apoptotic signaling (24, 77, 89). 
Apoptosis signaling has been reported in muscle and neuronal cells of aged rodents (4, 7, 26, 
34, 47, 77, 88, 130), and humans (44, 145). Aging-associated muscle denervation may also 
contribute to increased mPTP opening, that in turn induces apoptosis and muscle loss (76, 
133).
Similar to skeletal muscle cells, ROS damage to mitochondria in neurons from aged animals 
contributes to mPTP opening (53). This occurs through p66Shc which generates H2O2 that 
in turn, reacts with cytochrome c and induces oxidation of the mPTP and mitochondrial 
swelling (126). This mechanism is similar to neural degenerative diseases where induction 
of ROS (80, 113) contributes to motor neuron death (116). Thus, mitochondrial 
susceptibility to mPTP opening is a common point which triggers downstream cell 
destruction in both neuron and muscle cells.
Insufficient mitophagy allows unhealthy mitochondria to persist in aging 
muscles and neurons
Damaged mitochondria normally undergo fission then they are finally removed by 
mitophagy. However, mitophagy is attenuated with aging in skeletal muscle and motor 
neurons (40, 63, 70, 127). AMP-activated protein kinase (AMPK) and Sirtuin 1 (SIRT1) 
trigger the destruction of dysfunctional fragmented mitochondria through FoxO3-dependent 
autophagy (mitophagy) (94, 118). Mitofusin 2 (Mfn2) has an important role regulating 
mitochondrial fusion, but it also acts a receptor for Pink1 and Parkin-targeted mitophagy 
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(27). Recent data by Sebastián and colleagues (127) show that Mfn2 declines in muscle with 
aging and loss of Mfn2 produces an aging-like phenotype, including age-associated 
mitochondrial dysfunction, higher ROS accumulation and muscle fiber atrophy. Mfn2 has 
also been implicated in the loss of mitophagy in motor neurons. For example, a reduced 
inhibition of the E3 ligase Omi/HtrA2 in neuronal mitochondria contributes to a decrease in 
Mfn2 leading to attenuated mitophagy (29). Thus, an aging associated deficiency of Mfn2 
may be the bridge between impaired mitophagy and an accumulation of dysfunctional 
mitochondria in muscle and neurons during sarcopenia. However, it should be pointed out 
that other evidence does not support a decrease in Mfn2 or a decrease in the Mfn2 to Drp1 
ratio that would be expected if Mfn2 were suppressed in muscles of aged mice (75).
Defective mitophagy underlies the progression of motor neuron death in Amyotrophic 
lateral sclerosis (ALS) (38). In contrast, lithium-induced induction of mitophagy (38, 101) 
and mitochondrial biogenesis (101) improves mitochondrial morphology in motor neurons 
of a G93A SOD-1 mouse model of ALS. Other autophagy proteins, including Pink152, 
which is the cleavage product of the mitochondrial autophagy protein Pink1, has been 
implicated in the attenuation of mitophagy in motor neurons. Pink152 can exit the 
mitochondria in neuron cells and cleave Parkin, which then suppresses its translocation to 
the mitochondria to attenuate mitophagy (36).
Contrary data suggest that mitophagy may be increased in aging muscles as evidenced by 
greater migration of Parkin and p62 to the mitochondria (103). Nevertheless, an 
accumulation of lipofuscin granules suggests a failure of the lysosome to remove 
dysfunctional mitochondrial in aging even when Parkin has translocated to the mitochondria 
(103). Indeed, lipofuscin deposits have been reported previously in many tissues including 
muscles and neurons of aged rodents or other mammals (138). Further work is needed to 
determine if lysosomal dysfunction (136), loss of Mfn2, or some other protein involved in 
mitochondrial dynamics regulates mitophagy in sarcopenia.
Local apoptotic signaling in aging muscles and motor neurons becomes 
more wide spread to result in cell death
Our hypothetical model to explain the loss of single muscle fibers in sarcopenia is shown in 
Figure 2. This model assumes that local mitochondrial damage (potentially via ROS, high 
calcium loads, mtDNA damage etc.) causes increased mPTP opening, which triggers the 
contents of the mitochondria to leak to the cytosol. This initiates the intrinsic apoptotic 
signaling pathway leading to DNA fragmentation and nuclear apoptosis in a localized region 
of the fiber. An aging-suppression of autophagy activators like Sirtuin 1 (SIRT1) and Mfn2 
or other proteins involved in mitophagy, prevents removal of dysfunctional mitochondria via 
mitophagy and proteasome digestion.
The regional accumulation of damaged mitochondria could extend to other regions within 
the fiber via their connecting reticular network. As dysfunctional mitochondria accumulate, 
the region of the fiber that is engulfed by death signaling is expanded. We predict that 
eventually the entire fiber would be eliminated, presumably by involving the proteasome. 
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Genes of necrosis may also contribute to the overall cellular removal as sarcopenia 
progresses (26).
Cardiolipin is an important mitochondria-specific phospholipid, which is concentrated 
between inner and outer mitochondrial membranes, and redistribution of cardiolipin leads to 
a localized oligomerization of proapoptotic proteins (83). A local apoptotic cascade could 
occur via restricted remodeling and redistribution of cardiolipin adjacent to dysfunctional 
mitochondria. Furthermore, interaction of cardiolipin with the structural protein vimentin 
(104) could provide a localized cell-signaling site for targeted apoptotic disassembly and 
removal via anti-vimentin/CL complex antibodies, as has been observed in several 
pathologies involving apoptosis (104).
Our model for a localized apoptotic and proteolytic signaling cascade that expands to 
neighboring regions of a muscle fiber (Figure 2) has strong support from the work of Aiken 
and co-workers (26, 49, 50). For example, Cheema et al. (26) observed a localized aging-
induced loss of the mitochondrial enzymes succinate dehydrogenase and cytochrome c 
oxidase. Interestingly, the same fiber region that had mitochondrial disruption was both 
atrophic and had high levels of the apoptotic protein caspase-3. In contrast, fiber atrophy and 
apoptotic signaling did not occur in other regions of the same muscle fibers that were 
located further away from the dysfunctional mitochondrial (26). If the degenerative 
processes were not initiated locally but rather from a more general or systemic source, we 
would expect uniform muscle fiber wasting across its length, but this is not the case. 
Nevertheless, we predict that the progression of sarcopenia involves a gradual shift from 
targeted proteins in regions close to dysfunctional mitochondria to a strategy of non-targeted 
cellular destruction by activating the proteasome pathway when the apoptotic signaling 
expands to a wider fiber area.
We recognize that mitochondria are represented as distinct organelles in this simplistic 
model of localized signaling shown in Figure 2. However, mitochondria can range from 
small individual organelles, to rather extensive and connected reticular systems (57). In our 
model, mitophagy would be expected to target the regional area near dysfunctional 
mitochondria via the Pink1/Parkin and the LC3-II/autophagy receptor system for lysosomal 
removal. Although speculative, it is possible that elimination of a section of dysfunctional 
mitochondria could occur without disruption to the entire network of mitochondria along its 
reticulum. This could occur by activating fission signaling to wall off a healthy region of the 
mitochondrial reticulum from a region of dysfunctional mitochondria. Indeed, increased 
mitochondrial fission dynamics have been reported after muscle denervation (57) and in 
aging (55, 62). On the other hand, insufficient mitophagy in muscles from very old hosts 
could permit mitochondrial dysfunction in one area to affect other regions along the same 
mitochondrial reticulum and therefore affect a wider region of the cell.
We speculate that similar to our model in skeletal muscle fibers, motor neurons in aging 
hosts have increased mPTP opening, leading to apoptotic signaling, but dysfunctional 
mitochondrial are not removed because mitophagy is suppressed in aging. The apoptotic 
disassembly of motor neurons could begin regionally near dysfunctional mitochondria and 
spread to a wider area, resulting in motor neuronal death. Our speculation is supported from 
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data that show that in aging-associated neural diseases, there is a loss of mitochondrial 
function leading to increased mPTP sensitivity, and attenuated mitophagy that contributes to 
apoptosis (32, 68, 86, 99, 111). Nevertheless, we do not have data to support a process of 
aging associated localized motor neuron disassembly outside of neural degenerative disease. 
Additional work is needed to determine if localized loss of mitochondrial function 
contributes to a regional concentration of apoptotic signaling in motor neurons in the same 
way that it might occur in skeletal muscle cells with aging.
Altered mitochondrial dynamics with aging
Abnormal mitochondrial dynamics may negatively affect mitochondrial health. For example, 
both the mRNA level and the protein abundance of important fusion and fission proteins 
have been reported to be lower in old as compared to young adult skeletal muscle (55), and 
this would suggest that the potential for mitochondria to respond to changing environments 
might be reduced as compared to mitochondria from young hosts. Indeed, this appears to be 
the case, because electron microscopy and biochemical analyses have shown small, more 
fragmented mitochondria in muscles from old as compared to young adult hosts (56, 57), 
although very large mitochondria have also been noted in muscles from old animals (75). 
Consistent with the fragmented mitochondrial phenotype in muscles from old hosts, there is 
evidence to suggest that muscles of aged rodents and humans have a greater overall rate of 
fission vs. fusion (55, 62) and lower levels of the fusion protein Opa1 (62) as compared with 
younger muscles. Fragmented mitochondria tend to have a lower respiratory capacity, and a 
greater production of ROS, which increases the susceptibility of mitochondria to release its 
contents and activate the intrinsic caspase apoptotic pathway. Thus, it is not surprising that 
aging and disuse, which both have excessively fragmented mitochondria, are accompanied 
by muscle loss (57). It is interesting that a knockout of Mfn 1/2 in skeletal muscle, which 
prevented mitochondrial fusion, increased the accumulation of mtDNA defects and resulted 
in muscle atrophy (31). Together, these observations support for the idea that muscle 
mitochondria are important regulators of muscle size. However, to provide a balanced 
perspective it is important to point out that other studies have found higher fusion profiles in 
muscles of humans (14), and prematurely aged mice (63), and larger mitochondria in 
muscles of old mice (75). It is interesting that studies that have reported a higher fusion 
index in muscles from old rodents as indicated by ratios of Mfn1/Mfn2 (63) or Mfn2/Drp1 
(75) did not find changes in the protein contents of Mfn1, Mfn2, Opa1 or Drp1. Thus, even 
when higher fusion indexes are recorded there still may be more fragmented mitochondria in 
aged muscles
The impact of age-associated changes in the mitochondrial dynamics of motor neurons and 
their potential role in sarcopenia have not been studied. However, dysfunction of 
mitochondrial dynamics has been reported as an early event in Amyotrophic lateral sclerosis 
(61) which is a common motor neuron disease. Furthermore, increased mitochondrial 
fragmentation has been found to precede glutamate-induced death of motor neurons (143). 
Thus, similar to mitochondrial dynamic changes that have been proposed in muscle with 
aging, motor neuron dysfunction and death may converge upon mitochondria, and 
mitochondrial dynamics may play an important role in regulation of neuronal function that 
contributes to accelerated sarcopenia.
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FOXO proteins and the ubiquitin proteasome system (UPS) in muscle 
atrophy and sarcopenia
An acceleration of protein turnover with a net loss of protein is downstream of dysfunctional 
mitochondria but this represents a major contributor to sarcopenia. AMPK activation (118) 
and the Forkhead box class O (FOXO) transcription factor family regulates the ubiquitin 
proteasome system (UPS), and the autophagy-lysosome system. FOXO proteins also 
regulate the UPS, which is a tightly regulated system responsible for normal intracellular 
protein turnover and elimination of misfolded and dysfunctional proteins (72, 74). FOXOs 
control the mammalian target of rapamycin complex 1 (MTORC1) signaling, which is 
associated with muscle hypertrophy (43) and inhibition of mitophagy in skeletal muscle 
(23). FOXO regulation also occurs by MTORC1-mediated phosphorylation of ULK1 at 
Ser757 and the subsequent activation of the ULK1-ATG13- RP6KB/ribosomal protein 
p70S6 kinase (RB1CC1) in the UPS (23). Inhibition of MTORC1 in muscles of tuberous 
sclerosis complex (TSC) knockout mice, mimic many features of aging. This includes a loss 
of muscle mass and strength and attenuated mitophagy (23). However, protein turnover is 
tightly controlled because MTORC1 is upregulated in denervation-induced muscle atrophy 
(135). Interestingly, inhibition of MTORC1 reduced muscle atrophy via suppression of E3 
ligases, Muscle RING Finger 1 (MuRF1) and MAFbx/atrogin in response to denervation 
(135).
FOXO control of the UPS is important in the final steps of degradation of proteins in 
sarcopenia. FOXOs activate lysosomal cathepsins and cytosolic protease calpains which 
progresses towards ATP-dependent UPS activation via FOXO3a associated MuRF-1 and 
MAFbx regulation [reviewed in (66, 117)]. Thus, FOXO mediated autophagy via the UPS 
may be an important regulator of muscle mass in aging. In future studies it will be important 
to determine if failure to regulate FOXO control of MTORC1 or perhaps failure of other 
proteins that are in the pathways of anabolism might contribute to increased degradation of 
muscle proteins in aging.
Conflicting data highlight the complexity of understanding the importance of the UPS and 
atrogenes in sarcopenia. For example, ubiquitin (17), 26S proteasome, poly-ubiquitinated 
proteins (3), MuRF-1 and MAFbx expression were all reported to be elevated in hindlimb 
muscles of sarcopenic rats as compared to young adult animals (3, 30). Furthermore, 
ubiquitin was found to be greater in quadriceps muscles of older (70-79 yrs old) human 
subjects as compared to young adults (20-29 yrs old) (17). In contrast, MuRF-1 and MAFbx 
expression were reported to be lower in muscles of old rats than young adult rats (35) and 
not changed with aging in vastus lateralis of humans (145). The discrepancy between these 
studies might be due to variability introduced by a low number of subjects or animals in 
each study, and perhaps by some differences in the age and sex of the subjects that were 
studied. It is also possible that activity, nutritional history, health and smoking habits etc. 
will have affected MuRF-1 and MAFbx regulation in these studies. Thus, additional studies 
are warranted to understand the importance of the UPS in sarcopenia and the role of 
mitochondria in regulating the UPS more fully.
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UPS disruption increases dysfunctional mitochondria in muscle and neural cells
Aging associated neural diseases like Parkinson’s and Alzheimer’s disease, are associated 
with high ROS levels in neural cells. Reduced mitophagy associated Pink1- and Parkin-
regulated ubiquitination of the outer mitochondrial membrane of damaged mitochondria in 
aged neurons (79, 99, 140) contribute to a greater accumulation of ROS (81). High ROS can 
damage more mitochondria in muscle and neurons (81) and potentially elevate ROS levels 
even higher. It is therefore likely that proteasome dysfunction contributes to the higher 
potential for ROS generation in muscles and neuron cells of older individuals or animals.
An association between the UPS and mitochondria occur through a splice variant of the 
master mitochondrial regulator peroxisome proliferator-activated receptor gamma 
coactivator 1-alpha (PGC-1α). PGC-1α2, PGC-1α3, and PGC-1α4, have been shown to 
stimulate protein synthesis and attenuate UPS activity in cultured myotubes and mouse 
skeletal muscle (87, 119). Furthermore, PGC-1α reduces muscle protein degradation by the 
UPS via blocking nuclear factor κB (NF-κB) and FoxO3 activity (16, 124).
Cross talk between mitochondrial regulators of autophagy and the UPS
There is considerable communication between the UPS, mitochondrial regulators and 
governors of autophagy. For example, silent mating type information regulation 2 homolog 1 
(SIRT1) appears to be part of a pathway that regulates mitophagy. This pathway also 
involves AMPK, a master energy sensor (20). AMPK increases NAD+ levels, which 
activates NAD+-dependent SIRT1. Activated SIRT1 deacetylates and activates PCG-1α 
which promotes mitochondria synthesis, assembly, growth and mitochondrial antioxidant 
production (54). Deacetylation of FOXO1 and FOXO3a by SIRT1 (19, 20) mediates 
autophagic signaling in muscle cells, and aging attenuates SIRT1, which reduces autophagy 
(134). Furthermore, overexpression of SIRT1 reduces muscle wasting and innervation-
induced muscle atrophy by deacetylation and inhibiting FOXO1a and FOXO3 thereby 
inhibiting induction of MuRF-1 and MAFbx. Future studies should establish the relative 
importance of cross talk between PGC-1α, FOXO, SIRT1 and the UPS in aging muscles and 
motor neurons and establish how this affects sarcopenia.
Communication between mitochondrial induced death signaling in muscle and motor 
neuron cells accelerate cell death in aging
Cross talk between muscle and motor neurons are important to both tissues. This has been 
known for several decades, because when toxins or other compounds are injected into 
muscles, the compounds undergo retrograde transport to the neuromuscular junction (105), 
deposit in motor neurons (11), and sometimes contributes to motor neuronal dysfunction 
(reviewed in (33, 39). This communication is also seen when spinal cord injury or 
denervation induces large-scale muscle wasting (57, 76, 107, 129, 131, 137), and 
denervation is a condition often seen as part of sarcopenia. High levels of apoptotic signaling 
(1, 129) and altered autophagy signaling (102, 103) with elevated UPS activity (137) occurs 
in muscles after spinal cord injury or denervation. Thus, we would expect that altered 
neuronal signaling is due at least in part to high ROS production and mitochondrial 
dysfunction in the muscle cells, and conversely, that neural dysfunction will be 
communicated to muscle cells (57, 100).
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The health of muscle cells also affects motor neuron health. For example, increased muscle 
activity in male G93A SOD1 deficient mice contributes to greater motor impairment and 
motor neuron accelerated death (82). This implies that a feedback loop exists that conveys 
information about muscle activity and the condition of the muscle to the motor neuron. 
Further evidence of a muscle to motor neuron feedback pathway is supported from data 
showing increases in mitochondrial succinate dehydrogenase (SDH) activity in motor 
neurons following functional overload of the plantaris hindlimb muscle in cats (25). 
Furthermore, the presynaptic motor endplate of the neuromuscular junction is critical for 
providing retrograde transport to the motor neuron (98).
Observations from aging rats suggests that mitochondria in the axon terminals of the 
neuromuscular junction undergo swelling, in part from calcium overload. The resulting 
dysfunction of mitochondrial metabolism and dynamics contributes to elevations in cytosolic 
cytochrome c and caspase-3 (39). Furthermore, inhibition of synaptic loss reduces apoptosis 
of motor neurons in a mouse model of motor neuron disease (37). Together, these 
observations confirm that the same mitochondrial-induced initiation of apoptosis signaling 
that occurs in skeletal muscle also occurs in neuromuscular junctions with aging. We 
speculate that in aging, motor neurons receive feedback from deteriorating muscles and 
neuromuscular junctions and this communication in turn feeds to a loop of accelerated 
mitochondrial-induced degenerative changes in motor neurons. Although we cannot rule out 
the possibility that mitochondrial-induced apoptotic signaling and cell death may occur 
independently in muscle and motor neuron cells in aging, we have illustrated potential 
general feedback routes between muscle and motor neuron comparts that may affect the 
other tissue type, and if this occurs, we would expect sarcopenia to be accelerated (Figure 
1). Clearly, additional studies are need to test for the presence of these potential 
communication loops in aging.
Perspectives for Future Progress and the need for Future Studies
Our hypotheses is based on some speculation and therefore additional work is needed to test 
these hypotheses. Even if the mitochondrial centered hypothesis for sarcopenia is true, there 
are unknown factors that would be important to study in order that the information can make 
a practical impact on sarcopenia. A few of these questions are: As mitochondria damage 
may occur in several different ways (e.g., ubiquination, acetylation, succinylation, ROS 
damage to inner membrane, mtDNA damage, etc.), which of these (or other pathways) are 
the most important to sensitize mPTP opening to trigger apoptosis? What is the best strategy 
to combat mitochondrial dysfunction in aging? If exercise is considered to be a tool for 
reducing mitochondrial dysfunction, how would exercise target dysfunctional mitochondria? 
Is it necessary for muscle and neuron cells to improve mitochondria number or just remove 
dysfunctional mitochondria to slow or prevent sarcopenia? These questions are explored 
below, but the lack of clear information emphasizes the need for additional studies to 
provide these answers.
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What is the most important source of mitochondrial damage that triggers apoptosis and 
cell death?
We have focused on ROS damage to the inner mitochondrial membrane (15, 21, 22, 79) and 
mtDNA damage (22, 26, 50, 63, 73) as two important ways that might impair mitochondrial 
function in aging muscles and motor neurons. However, mitochondria damage and 
modifications may also occur by posttranslational modifications such as ubiquitination (67, 
99, 140, 148), acetylation (9, 21, 28), succinylation (114, 150), and phosphorylation (51, 73, 
79). Other potential sources of mitochondrial damage include excessive calcium loading (9, 
28). Likely some damage is repairable, whereas other damage contributes to irreparable 
mPTP opening leading to nuclear apoptosis and cell death. It is important to identify which 
of these (or other pathways) provide potential reversible mitochondrial damage and which 
cause irreversible damage that promotes apoptosis.
Potential strategies using exercise and nutrition to reduce sarcopenia should focus on 
mitochondrial health
Exercise interventions and nutritional manipulations have produced some successes for 
reducing although not fully eliminating sarcopenia. A logical place to begin the search for 
ways by which exercise and nutritional approaches might better attenuate sarcopenia is by 
targeting these strategies to maximize mitochondria health. This includes identifying the 
mitochondrial modifications that are reversible by exercise and nutritional interventions in 
aging. For example, mitochondrial acetylation is reversible at least under some 
circumstances including exercise (97). Proteins like SIRT1 and SIRT3 may be important 
regulators of deacetylation in mitochondria (46, 97, 132). SIRT1 is important for 
deacetylation of mitochondrial-interacting targets like PGC-1α, FOXO3, p53 and NF-kB 
(Reviewed in (13, 110) and has been implicated in improving function and life span in aging 
(95). Furthermore, SIRT1 deacetylation of Mfn2 may be important for regulating mitophagy 
and removing dysfunctional mitochondria (132). In addition, evidence from non-muscle and 
non-neuronal cells suggests that mPTP-mediated pore opening and apoptosis can be 
inhibited by deacetylation of mitochondria by SIRT3 (46).
Exercise training and nutrition could be used as an intervention to increase SIRT1 and 
SIRT3 activity with the goal of increasing mitophagy and mitochondrial biogenesis 
pathways in muscle and neuronal cells. However, aging is associated with high cell levels of 
ROS and ROS accumulation is an inductor for mPTP opening. ROS accumulation could 
increase with exercise, and this may be why exercise has only been partially successful in 
reducing sarcopenia. We postulate that nutritional regulation of oxidants should be 
considered to minimize the additional ROS burden (58, 59, 120-122) when initiating 
exercise training in the elderly to minimize mPTP opening. Future studies could test if 
nutritional antioxidants would minimize excessive ROS accumulation, oxidant damage and 
mPTP opening in muscles and neurons when elderly persons begin an exercise program. If 
this were the case, we would predict that antioxidant supplements should be slowly reduced 
after some duration of training adaption has past, to permit cellular increases in SIRT1/
SIRT3 and antioxidant defenses for the elderly subjects without risking excessive ROS 
damage.
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How might exercise target dysfunctional mitochondria by mitophagy?
Studies in rodents have shown an increased abundance of autophagy proteins including Drp1 
and Bcl-2 and 19 kDa interacting protein-3 (Bnip3) after exercise (60, 65, 71, 78). Bnip3 
functions as a mitophagy receptor to recruit selected autophagosomes for elimination. 
Exercise-induced Pink1 activation of Drp1 (112) could also target dysfunctional 
mitochondria for mitophagy. This idea is supported by recent data from Mejias-Pena et al. 
(92) who found an increase in the protein abundance of autophagy proteins Beclin-1, Atg12, 
Atg16, and the LC3II/I ratio in blood mononuclear cells of elderly subjects after 8 weeks of 
aerobic exercise. Furthermore, 8 weeks of aerobic exercise has been reported to increase 
autophagy proteins Beclin-1, ATG7, and MuRF-1 in muscles of old mice (70). Indeed, it has 
been proposed that autophagy signals are necessary to achieve aerobic improvements in 
skeletal muscle (78). Thus, autophagy proteins may be important for an exercise-mediated 
slowing of sarcopenia. If the same processes occur in humans as is the case in rodents and 
non-human mammals (64), exercise, or nutritional intervention such as caloric restriction 
would also be expected to increase mitophagy removal of dysfunctional mitochondrial, so 
the mitochondria that remain are proportionally healthier (64).
Although clearly speculative, we postulate that in response to exercise or nutritional 
interventions, mitochondria that are the most dysfunctional would provide the greatest 
magnitude of apoptotic signaling and be more likely to attract autophagy linker proteins 
(e.g., p62) for elimination by mitophagy. Future studies are needed to identify the precise 
signatures of local death signaling around individual dysfunctional mitochondria and to 
determine which autophagy receptors are reduced by exercise or nutritional interventions 
and to examine if activated LC3-II is attenuated or eliminated once dysfunctional 
mitochondria are removed. This will take technology that is able to identify dysfunctional 
from healthy mitochondria and sample the milieu adjacent to each mitochondria.
Although speculative, exercise or nutritional modifications might target dysfunctional 
mitochondria for elimination is via an autophagy pathway called chaperone-mediated 
autophagy (CMA). CMA involves the binding of constitutive heat shock 70 to selected 
proteins, which are targeted to the lysosomal membrane where they interact with membrane 
receptor lysosomal-associated membrane protein 2A (LAMP2A). Aging causes degradation 
and availability of LAMP2A in the lysosomal membranes (69), which reduces the 
effectiveness of CMA. Future studies should evaluate the role of LAMP2A and determine if 
exercise or nutritional interventions increase CMA and target dysfunctional mitochondrial 
for mitophagy in muscles and motor neurons of old animals or humans.
Another potential way that exercise could selectively target dysfunctional mitochondria is 
through elevation of Parkin or the degradation of PARK7/DJ-1 (142). PARK7 is an 
antioxidant protein that limits mitochondrial damage in response to oxidative stress (12) and 
it regulates skeletal muscle contractile protein synthesis and hypertrophy (149). 
Overexpression of PARK7 reduces mitochondrial dysfunction under oxidative stress (142) 
which shows a direct link between autophagy and mitochondrial function. Future studies 
should identify if exercise or nutritional intervention (e.g., antioxidants, caloric restriction) 
improves PARK7 expression in muscles and motor neurons of old hosts and if the change in 
PARK7 directly mediates improvements in mitochondrial function of skeletal muscle.
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Parkin and Pink1 are attractive candidates for targeting dysfunctional mitochondria, which 
we speculate would occur in response to exercise. This is because accumulation of Pink1 at 
the outer mitochondrial membrane provides a precise mechanism to identify dysfunctional 
mitochondria from healthy ones. Pink1 promotes Parkin recruitment to activate mitophagy 
and UPS signaling. However, overexpression of PGC-1α was reported to attenuate Pink1 
levels in response to remobilization of muscle (67). As we would expect exercise to increase 
mitochondrial biogenesis through the PGC-1α axis, it is not known if Pink1 plays an 
important role in an exercise-mediated increase in mitophagy of muscle cells and motor 
neurons of aged humans or rodents.
The potential role for mitochondrial biogenesis to reduce sarcopenia
In addition to increasing mitophagy, exercise and nutritional interventions might be expected 
to increase mitochondrial biogenesis and therefore replace the dysfunctional mitochondria 
that are removed by mitophagy. Both endurance and resistance exercise have been associated 
with elevated mitochondrial biogenesis (93, 109). Relative mitochondrial activity 
corresponds with fractional protein synthesis rates, because many proteins complete their 
translation at mitochondria (84). There is an assumption that endurance and strength training 
by older adults induces mitochondrial biogenesis, but given the propensity for mtDNA 
damage and high ROS levels in aging, this remains uncertain. If newly synthesized 
mitochondria were generated in exercised muscles and motor neurons from aged hosts, but 
the new mitochondrial were unhealthy (e.g., incompletely folded proteins), the mitophagy 
signals (from exercise or nutritional interventions) would need to be even higher to remove 
these newly formed but dysfunctional mitochondria. Clearly, additional work is needed 
before we fully understand if exercise or nutritional interventions synthesize completely 
functional and healthy mitochondria in aged hosts, or if the basal environment of oxidative 
stress etc. results in a new population of unhealthy mitochondria that must also be targeted 
for mitophagic removal in the elderly.
We know that exercise downregulates apoptosis and upregulates mitophagy (4, 52, 128, 
146). Nevertheless, future studies should explore the mechanisms by which exercise 
activates mitophagic, and attenuates apoptotic, and necrotic signaling pathways in muscle 
cells and motor neurons of older individuals (4, 47). We recognize that increased apoptosis 
and reduced mitophagy have not been identified as an aging-related condition in every study, 
but in our view, there is sufficient data to suggest that this is probably an underlying process 
for most cells in aging. Nevertheless, some of the mitochondrial mediated pathways leading 
to motor neuron death in aging have not received much attention and should be the 
investigation of future work.
Future experiments should also identify novel proteins and protein functions that better 
define the communication of dysfunctional signaling between motor neurons and muscle 
cells in aging. Modern genetic approaches, including RNA-seq and proteome pathway 
analysis, will likely be required. It will also be important to find out if it is possible to 
reverse the process responsible for regional disassembly in the absence of mitochondrial 
biogenesis, and then to focus on molecular events and targets in muscle and motor neurons 
that are upstream of this point. In the quest to attenuate sarcopenia, it will also be important 
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to understand the limit for mitochondrial health to impact satellite cell function for repairing 
and replacing sections of fibers or whole fibers, as satellite cells are affected adversely by 
aging, mitochondrial damage and death signaling (4, 6, 7, 144).
Conclusions
Mitochondrial-regulated apoptosis provides a strong signaling network that contributes to 
sarcopenia (8). We have taken the perspective that both neural and muscle components 
contribute to muscle wasting but mitochondrial health is central to initiating and 
perpetuating the signal for sarcopenia. We argue that mitochondrial dysfunction leads to 
increased mPTP opening and initiates apoptotic signaling in muscle cells and motor neurons. 
In aging, this is not corrected because mitophagy is inhibited. Proteasome activation leads to 
removal of cellular contents close to the site of dysfunctional mitochondria, and this cellular 
dismantling expands proportionally to the accumulation of dysfunctional mitochondria. 
Although aging induces wide spread systemic mitochondrial dysfunction, perhaps as a result 
of high ROS or accumulation of mtDNA damage, we have considered that retrograde and 
anterograde communication likely exists between dying muscle and motor neurons, which 
may accelerate death in both compartments.
Additional studies are needed to establish if exercise and nutrition can be used to effectively 
improve mitochondria health and reduce sarcopenia in aging populations. In our view, 
targeting dysfunctional mitochondria and increasing healthy mitochondria in motor neurons 
and muscle fibers provide the best strategy for reducing sarcopenia.
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• Aging-induced mitochondrial insult in muscle and neurons (e.g., oxidative 
stress, DNA damage, posttranslational modifications) results in mitochondrial 
permeability transition pore opening.
• Mitophagy signaling normally removes dysfunctional mitochondria, but this 
process is impaired in aging muscle cells and motor neurons.
• Release of the contents from dysfunctional mitochondria to the cytosol 
initiates local apoptotic signaling, that if left unchecked activates nuclear 
fragmentation, cell death and proteasome activation for cell removal.
• Cross talk between dysfunctional muscle and motor neuron cells exacerbates 
the sarcopenic loss of muscle mass and function.
• To prevent sarcopenia, future studies should identify strategies that reverse 
mitochondrial modifications to prevent opening of the mitochondrial 
permeability pore and increase mitophagy in muscle and neuronal cells.
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Figure 1. Mitochondrial Regulated Sarcopenia
Induction of mitochondrial stress (lightning bolt) can result in dysfunctional mitochondria. 
Damaged mitochondria are engulfed in an autophagosome membrane and removed by 
mitophagy signaling in healthy young muscle and motor neurons. However, aging is 
associated with increased ROS and other mitochondrial stresses, which enhance mPTP 
opening. Release of the mitochondrial contents to the cell cytosol induces an apoptotic 
cascade ending with DNA fragmentation and removal of nuclei. Sufficient nuclear death in 
muscle cells will result in the death and removal of the entire muscle cell. Similarly, motor 
neuron death occurs when apoptosis removal of the alpha motor neuron nucleus occurs. The 
interdependence of muscle cells and motor neurons suggests a potential feedback loop 
(anterograde and retrograde) communication between the muscle and the motor neuronal 
compartments, which exacerbates death in both compartments. Death in these cell 
compartments leads to loss of muscle mass and function in aging. Thus, dysfunctional 
mitochondria provide the signal to initiate sarcopenia.
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Figure 2. Hypothetical model for eliminating muscle fibers in sarcopenia via localized 
mitochondrial associated dysfunction – mitophagy and apoptosis
A. In healthy muscle, activation of mitophagy eliminates dysfunctional nuclei so that they 
cannot continue death signaling. B. Dysfunctional mitochondria that leak their contents to 
the cytosol will occur in muscle that has received a significant mitochondrial stress (e.g., 
ROS, inflammatory mediators etc.). C-D. This initiates the apoptotic signaling cascades. E-
F. If the dysfunctional mitochondria are not eliminated, apoptotic death signaling may be 
activated to eliminate myonuclei and this may concurrently or independently result in wide-
spread activation of autophagy and the ubiquitin ligase pathway and also, trigger the 
necrosis signaling pathway to remove muscle proteins, mitochondria and nuclei within the 
domain of the initial dysfunctional mitochondria (G-H). I-J. The extent of dysfunctional 
mitochondrial will extend along the mitochondrial reticular network and affect the function 
of other mitochondria near the dysfunctional mitochondrial. The wider accumulation of 
dysfunctional mitochondria will perpetuate signaling for apoptosis, which will remove 
nuclei from a larger area. The greater nuclear loss will be followed by elevated proteasome 
signaling to eliminate contractile and non-contractile tissue in the fiber segment that is 
associated with dysfunctional mitochondria and apoptotic signaling. This cellular removal 
will result in eventual elimination of the portion of the fiber in the area of the dysfunctional 
mitochondrial and potentially the entire fiber. We further hypothesize that the initiation of 
the disassembly and removal of the fiber could be blocked if the dysfunctional mitochondria 
which initiate the process, are removed or the damage to mitochondria reversed (e.g., via 
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exercise and nutritional interventions) and if irreparable damaged mitochondria are replaced 
by healthy mitochondria.
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